VitaSpring Biomedical Co. Ltd. VSBC
OTC PK
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 14.15% | 35.70% | 46.41% | 44.37% | 40.76% |
| Total Depreciation and Amortization | -8.00% | 0.00% | 0.00% | -11.50% | -20.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -181.45% | -119.63% | -111.22% | -107.61% | -92.15% |
| Change in Net Operating Assets | -0.79% | -15.08% | -22.80% | -9.53% | -6.99% |
| Cash from Operations | 203.92% | 136.84% | 81.51% | 70.13% | 24.44% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -63.64% | -61.90% | -70.00% | -70.00% | -54.17% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -63.64% | -61.90% | -70.00% | -70.00% | -54.17% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 362.50% | 920.00% | 500.00% | 80.00% | -220.00% |